MEDA to Acquires Acton Pharmaceuticals

Article

Meda will acquire Acton Pharmaceuticals.

The specialty pharmaceutical company, Meda has agreed to acquire Acton Pharmaceuticals, a specialty respiratory company.  Acton’s lead product is Aerospan. Aerospan is an inhaler for the treatment of asthma that contains the active substance flunisolide.

The launch of Aerospan is expected to begin in 2014 for $135 million plus $10 million in a contingent, near-term development milestone. Acton will also receive certain sales-based milestones, which may bring the total potential acquisition value of up to $200 million.

Source: Meda

Recent Videos
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Adragos Pharma Completes Liquid Filling Line Installation in Germany

Patrick Lavery
March 7th 2025
Article

The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Makes Class-Wide Labeling Changes to Testosterone Products

Patrick Lavery
March 6th 2025
Article

The alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Ross Announces PFA-Coated Ribbon Blender to Be Offered for Sensitive Applications

Patrick Lavery
March 6th 2025
Article

The company said this blender supports applications for which either stainless steel or carbon steel may not be suitable.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CordenPharma Selects Switzerland Site for Peptide Manufacturing Facility

Patrick Lavery
March 5th 2025
Article

The company first announced its intention to build the state-of-the-art facility as part of a €900 million investment in July 2024.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Nelson Labs Launches Rapid Sterility Testing, Cutting Incubation Times

Patrick Lavery
March 4th 2025
Article

The company now performs product-sterility testing through rapid microbiological methods at two laboratory sites in the United States and one in Germany.